[Bronchodilating effect of Berotec in bronchial asthma].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D009921:Metaproterenol / Q000627:therapeutic use*; D008875:Middle Aged; D010636:Phenols / Q000627:therapeutic use; D010919:Placebos
D001993:Bronchodilator Agents; D010636:Phenols; D010919:Placebos; D009921:Metaproterenol
Obserwacje nad działaniem leku Berotec w dychawicy oskrzelowej.